1037 GMT - Major pharmaceutical stocks GSK and AstraZeneca, alongside aerospace and defense stocks Rolls-Royce and Melrose, are among the biggest FTSE 100 fallers ahead of Trump's tariff announcement later Wednesday. These stocks would be "in the firing line if Trump doesn't give the U.K. special treatment," says AJ Bell's Russ Mould in a note. Many investors hope the U.K. could be spared the worst of the tariffs. However, if U.K. Prime Minister Keir Starmer fails to secure a better deal, companies within pharma, food and drink, aviation, chemical and automotive sectors would be vulnerable, he says. Rolls-Royce is the biggest FTSE 100 faller, down 3.4%; GSK falls 3.2%; Melrose loses 2.6% and AstraZeneca is down 2.3%. The FTSE 100 falls 0.7%. (jessica.fleetham@wsj.com)
(END) Dow Jones Newswires
April 02, 2025 06:37 ET (10:37 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。